Hotline:400-8201-126 中文 | English

Aims to become a giant in the global blood products industry

At present, among the core R & D team in company, 22% and 45% of them are holding Ph.D.’s master's degree respectively with the average age of 35 years old. It is cross-disciplinary, strong and vibrant team. With the development of company, excellent R & D personnel have joined the research team of Shanghai RAAS. In addition to well-known institutions such as Fudan University, East China University of Science and Technology, there are also a number of talents from overseas universities, like University of Pennsylvania, the Children's Hospital Philadelphia, Oklahoma Medical Research Institute, University of Tokyo, is a global vision to create an international independent research and development team.

RAAS bio-medical research center was evaluated as Minhang district research center in 2010.

Dr Hui Lu, leader of R&D team, has worked in University of Pennsylvania and Hematology department of the Children's Hospital Philadelphia. His research interest is focusing on developing novel therapy for hemophilia like gene therapy. There are more than 10 publications. He has presided over 1 national science fund project, 1 “Major New Drugs Innovation and Development” project from ministry of science and technology, and participated in 2 key scientific projects from Science and Technology Commission of Shanghai Municipality. He also participated in writing book “Molecular Gene Medicine” and 1 patent. 

Links:Tonrol Bio-Pharmaceutical Co., Ltd.,

Internet drug information service certificate :( Shanghai) Non-operating 2011-0201  Copyright © 2013-2014 Shanghai RAAS   All rights reserved  Powered by Yongsy